- Telehealth visits
- Insurance plan information
Neil P. Shah, MD, PhD
Hematology and Medical Oncology- Telehealth visits
- Insurance plan information
Neil P. Shah, MD, PhD
Hematology and Medical Oncology- Telehealth visits
- Insurance plan information
On this page
Education & training
Board certification
- Hematology, American Board of Internal Medicine/Hematology
Fellowship
- Hematology - Oncology, University of California Los Angeles
Residency
- Internal Medicine, University of California Los Angeles
Degree
- MD, University of California Los Angeles
Academic title
- Professor-in-Residence
My expertise
Specialties
Conditions
Locations
My research
Publications
Showing 1-6 of 58 reviews
- July 30, 20265 out of 5 Stars
Dr. Neil Shah is an outstanding doctor and a wonderful person. He goes above and beyond to inform me and make me feel safe. I feel very fortunate to have him as my Oncologist.
- July 14, 20265 out of 5 Stars
Dr. Shah is the best. He is always looking out for Me and my other issues. He recommended I enroll in the UCSF headache clinic. Always compassionate. Always kind. I'm always grateful for his care.
- June 20, 20265 out of 5 Stars
Dr. Shah is absolutely the best medical professional I've ever interacted with. Knowledgeable, kind, patient. He is the gold standard!
- June 13, 20265 out of 5 Stars
Dr. Shah is 1000% wonderful. I'm so happy to have him as my specialist.
- June 4, 20265 out of 5 Stars
Dr. Shah's care is excellent. I trust him completely. He cares about the side effects I'm experiencing and takes them into account when we discuss treatment going forward.
- May 21, 20265 out of 5 Stars
Dr. Shah is the best!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.